Living Cell Technologies considers 'medical tourism' 26 Aug 2016
Related articles
- Brownlee Leads Aviation Mission To Shanghai News
- Knowles quits as CEO of KiwiBank Business
- Sludge Report #192: The Naked Budget Columns
- NZ manufacturing activity reaches highest since 04 Business
- Budget provides $321m for RS&T activities News
- Licensing To Cut Out Cowboy Advisers Migration
- Government Widens Drought Assistance News
- Young People Take Over Parliament News
- Actions For Young Driver Safety Get Green Light News
Living Cell Technologies considers 'medical tourism' if Parkinson's therapy trial succeeds
By Fiona Rotherham
Aug. 26 (BusinessDesk) - Australasian biotech company Living Cell Technologies plans to treat patients for Parkinson’s disease under a “medical tourism” model if its clinical trial under way in Auckland succeeds next year.
The phase 11b clinical trial of 18 patients is underway at the University of Auckland and Mercy Hospital on its regenerative cell therapy NTCELL, which would be the world’s first disease-modifying treatment for Parkinson’s.
Results are expected mid-next year from the escalating dosage clinical trial which is being carried out in three legs and requires consent from the Data Safety Monitoring board at the end of each 26-week period after the cells are implanted.
Living Cell chief executive Ken Taylor said if the second trial proves successful, the company will apply for provisional consent that would speed up approval for treatments for severe illnesses that speed up approval to treat paying patients in New Zealand next year, including patients brought in from other countries.
Medical centres of excellence that attract paying patients from other countries are common overseas, he said.
“It would be quite good when launching it to keep tight management on it to make sure implementation is being done properly,” Taylor said.
The next step on from medical tourism under its business strategy is scaling up the GMP manufacturing process, developing NTCELL for other central nervous system diseases such as Huntington’s and Alzheimer's, and expanding its use worldwide.
Living Cells’ operations are based in New Zealand and it’s listed on the ASX and US stock exchanges.
It reported a narrowed annual loss this week of A$3 million for the year ended June 30 from A$7 million the prior year.
It was founded in New Zealand in 1999 to develop a regenerative cell therapy that involves transplanting cells from Auckland Island pigs into humans. The initial target was type 1 diabetes, which is now being pursued by its joint venture company, Diatranz Otsuka Ltd (DOL).
In 2014 DOL licensed Living Cell’s other 50 percent partner, Japanese-based Otsuka Pharmaceutical Factory, to use DIABCELL in the US and Japan and last year DOL decided to carry out research in the US in order to meet strict Food and Drug Administration (FDA) rules, rather than in New Zealand. It is now consulting with seven full and part-time employees about closing its Invercargill pig facility and with the Southern Heirloom Breeds Trust about rehoming the 30 pigs.
DOL has completed Phase 1 and 2 trials of DIABCELL in New Zealand, Russia, and Argentina and general manager Shaun Wynyard said it is still some years away before the product will be brought to market.
As part of its commercialisation plans, Living Cell secured supply of its lead product NTCELL by paying A$580,000 for plant and equipment and pathogen-free pigs now held at a North Island pig breeding facility. Taylor said it has sufficient supply of NTCELL as Parkinson’s requires fewer cells than the diabetes treatment.
Living Cell’s smaller loss was mainly due to a markedly reduced share of joint venture losses as the carrying value of the investment has been reduced to zero. The company’s share of unrecognised losses through the joint venture is A$3.5 million.
It still has plenty of cash in hand - A$5.3 million compared to A$5.1 million the year before, following a A$3.7 million fund-raising through private placements and a share purchase plan, partially offset by clinical trial and operating costs.
Research and development costs increased to A$2.36 million from A$1.77 million the prior year after completion of the first clinical trial and the start of the second, along with maintaining the pig herd.
Grant income more than doubled during the year to A$592,000 from A$228,000 after gaining a three-year Callaghan Innovation research and development grant.
(BusinessDesk receives funding from Callaghan Innovation to assist coverage of the commercialisation of innovation)
(BusinessDesk)
News
Hilary Timmins' Award-Winning UK Documentary Series To Inspire NZ Students
29 Jun 2020 Education
Dream Catchers, produced and directed by Hilary Timmins, celebrates the success stories of more than thirty inspirational New... more
New Zealand reaffirms support for Flight MH17 judicial process
7 Mar 2020 News
Ahead of the start of the criminal trial in the Netherlands on 9 March, Foreign Minister Winston Peters has reaffirmed the need to... more
Business
NZ Government's Economic package to fight COVID-19
17 Mar 2020 Business News
The Coalition Government has launched the most significant peace-time economic plan in modern New Zealand history to cushion the... more
NZ Government announces aviation relief package
19 Mar 2020 Business News
Transport Minister Phil Twyford today outlined the first tranche of the $600 million aviation sector relief package announced earlier... more
Living
Diversity was Key at New Zealand Trade Tasting in London
6 Jun 2022 Food & Wine
New Zealand Winegrowers Annual Trade Tasting was recently held in London, on Wednesday 4 May, in Lindley Hall.
It was the first... more
Kiwi author stuns Behind the Butterfly Gate
12 Jan 2022 Arts
Hidden behind the Butterfly Gate is where the secret has been kept for 76 years...
New Zealand writer Merryn Corcoran’s... more
Property
Fairer rules for tenants and landlords
17 Nov 2019 Property
17 NOVEMBER 2019
The Government has delivered on its promise to the over one million New Zealanders who now rent to make it fairer... more
New Zealand Government will not implement a Capital Gains Tax
17 Apr 2019 Property
The Coalition Government will not proceed with the Tax Working Group’s recommendation for a capital gains tax, Jacinda Ardern... more
Migration
Boosting border security with electronic travel authority – now over 500,000 issued
19 Nov 2019 Migration
19 NOVEMBER 2019
We’ve improved border security with the NZeTA, New Zealand Electronic Travel Authority, which helps us to... more
Christchurch reinstated as refugee settlement location
18 Aug 2018 Migration
18 AUGUST 2018
HON IAIN LEES-GALLOWAY
The announcement that Christchurch can once again be a settlement location for refugees... more
Travel
Gallipoli Anzac Day services cancelled
19 Mar 2020 Travel & Tourism
The New Zealand and Australian Governments have announced this year’s joint Anzac Day services at Gallipoli will be cancelled... more
New Zealanders advised not to travel overseas
19 Mar 2020 Travel & Tourism
New Zealanders advised not to travel overseas
more
Sport
The Skipper's Diary: Sir Richard Hadlee honouring his father and NZ's Forty-Niners
27 Oct 2019 Cricket
NZNewsUK London Editor Charlotte Everett spoke to Sir Richard Hadlee about why he’s chosen to publish his father’s... more
PREVIEW: All Blacks v England semi-final
26 Oct 2019 Rugby
The two most convincing quarterfinals winners are set to square off in a semifinal showdown for the ages when the All Blacks meet old... more
Columns
Gordon Campbell on the Gareth Morgan crusade
11 Nov 2016 Opinion
Gordon Campbell on the Gareth Morgan crusade
First published on Werewolf
The ghastly likes of Marine Le Pen in France and Geert ... more
Gordon Campbell on the US election outcome
10 Nov 2016 Opinion
Column - Gordon Campbell
Gordon Campbell on the US election outcome
Well um.. on the bright side, there (probably)... more
Kiwi Success
Congratulations to Loder Cup winner
26 Sep 2018 People
25 SEPTEMBER 2018
The Loder Cup, one of New Zealand’s oldest conservation awards, has been awarded to Robert McGowan for 2018... more
Appointments to New Zealand National Commission for UNESCO
16 Aug 2018 Appointments
16 AUGUST 2018Appointments to New Zealand National Commission for UNESCO
HON JENNY SALESA
Associate Education Minister Jenny Salesa is... more
Recruitment
Historic pay equity settlement for education support workers
14 Aug 2018 Recruitment
14 AUGUST 2018Historic pay equity settlement for education support workers
RT HON JACINDA ARDERN
HON CHRIS HIPKINS
Prime Minister
The... more
Historic pay equity settlement for education support workers
22 Aug 2018 Recruitment
14 AUGUST 2018Historic pay equity settlement for education support workers
RT HON JACINDA ARDERN
HON CHRIS HIPKINS
Prime Minister
The... more